Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]

Bibliographic Details
Main Authors: Tang Ziyang, Hu Xirong, An Chongming, Li Tingxin
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Biomedicine & Pharmacotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223015858
_version_ 1797630619394506752
author Tang Ziyang
Hu Xirong
An Chongming
Li Tingxin
author_facet Tang Ziyang
Hu Xirong
An Chongming
Li Tingxin
author_sort Tang Ziyang
collection DOAJ
first_indexed 2024-03-11T11:10:44Z
format Article
id doaj.art-95d8d89d5f3249218a47709cee00609d
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-11T11:10:44Z
publishDate 2023-12-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-95d8d89d5f3249218a47709cee00609d2023-11-12T04:39:19ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-12-01168115787Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]Tang Ziyang0Hu Xirong1An Chongming2Li Tingxin3Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR ChinaFaculty of Nursing, Xi’an Jiaotong University, Xi’an, PR ChinaDepartment of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, PR ChinaDepartment of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, PR China; Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, PR China; Corresponding author at: Department of Health Management & Institute of Health Management, Sichuan Provincial People’s Hospital, Chengdu, PR China.http://www.sciencedirect.com/science/article/pii/S0753332223015858
spellingShingle Tang Ziyang
Hu Xirong
An Chongming
Li Tingxin
Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
Biomedicine & Pharmacotherapy
title Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
title_full Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
title_fullStr Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
title_full_unstemmed Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
title_short Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
title_sort corrigendum to the potential molecular pathways of astragaloside iv in colorectal cancer a systematic review biomed pharmacother 167 2023 115625
url http://www.sciencedirect.com/science/article/pii/S0753332223015858
work_keys_str_mv AT tangziyang corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625
AT huxirong corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625
AT anchongming corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625
AT litingxin corrigendumtothepotentialmolecularpathwaysofastragalosideivincolorectalcancerasystematicreviewbiomedpharmacother1672023115625